Skip to content

 

Changes to the Supervisory Board and Management Board

Changes to the Supervisory Board

The Annual General Meeting of Fresenius SE & Co. KGaA on May 13, 2022 elected Dr. Christoph Zindel to the Supervisory Board of Fresenius SE & Co. KGaA. Dr. Christoph Zindel is a member of the Audit Committee of the Supervisory Board.

As announced a year ago, Klaus-Peter Müller stepped down from the Supervisory Board at the end of the Annual General Meeting on May 13, 2022 and handed over the chairing of its Audit Committee to Susanne Zeidler.

Changes to the Management Board

Michael Sen has been Chief Executive Officer of Fresenius since October 1, 2022. He was appointed unanimously by the Supervisory Board of Fresenius Management SE to succeed Stephan Sturm, who left the Company on good terms on September 30, 2022. Michael Sen will, in addition, continue to serve as CEO of Fresenius Kabi until a successor is decided for this position.

The Fresenius Management SE Supervisory Board has unanimously appointed Sara Hennicken as the Company’s new Chief Financial Officer as of September 1, 2022. She succeeds Rachel Empey, who joined the Management Board of Fresenius as CFO on August 1, 2017, and left the Company at her own request at the end of August.

Helen Giza has been appointed Chief Executive Officer of Fresenius Medical Care effective December 6, 2022. Previously, she was Vice-Chair of the Management Board of Fresenius Medical Care. The Supervisory Board of Fresenius Medical Care Management AG unanimously appointed her to succeed Dr. Carla Kriwet, who left the company at her own request and by mutual agreement due to strategic differences.

Dr. Carla Kriwet succeeded Rice Powell on October 1, 2022, who retired after 10 years at the helm of the company in accordance with the age limit for Executive Board members. Rice Powell resigned as CEO on September 30, 2022. Helen Giza will continue to serve as Chief Financial Officer of Fresenius Medical Care until her successor is appointed. As Chief Executive Officer of Fresenius Medical Care, Helen Giza is also a member of the Management Board of Fresenius Management SE. Dr. Carla Kriwet has resigned from the Management Board of Fresenius Management SE.

The Supervisory Board of Fresenius Management SE has appointed Pierluigi Antonelli as the new Chief Executive Officer of Fresenius Kabi effective March 1, 2023. He takes over from Michael Sen, who had continued in this position on an acting basis after his appointment as Chairman of the Management Board of Fresenius SE on October 1, 2022. The Human Resources, Risk Management and Legal department will be expanded to include Environmental, Social and Governance (ESG). Sebastian Biedenkopf will leave the company by mutual agreement when his contract expires at the end of the year. He will be available to his successor Michael Moser, who will take up his post no later than August 1, 2023, until the end of his contract to ensure a smooth handover.

The CVs of the members of the Supervisory Board and the Management Board can be found on our website at https://www.fresenius.com/Corporate-Management.